• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Reaching the Healthcare Mainstream: Wearables and Remote Patient Monitoring Market Map

by Healthcare Growth Partners (HGP 06/21/2019 Leave a Comment

Even though 2014 was supposed to be the “year of the wearable” according to Forbes, five years later we are now seeing the wearable reach maturity and mass-adoption.  This increase in adoption has largely been driven by software and hardware stability which is now allowing these devices to be used with confidence to manage an individual’s health and wellness, including chronic condition management. The graphic below from Accenture shows the increase in technology usage across consumers to manage their health from 2016 to 2018.

Reaching the Healthcare Mainstream: Wearables and Remote Patient Monitoring

Wearable technology is a rapidly growing market which includes devices that are consumer-oriented such as fitness monitors as well as medically oriented devices, such as mobile ECGs. The market in 2018 reached approximately $26 billion in worldwide revenue and is projected to grow to $34 billion by the end of 2019 – $15 billion of which is expected to be generated from healthcare and medical environments.  While a large portion of the market centers on commonly known smartwatches such as the Apple Watch, there has been growth in earworn devices, smart clothing, and wearable ECGs.  Earworn devices are expected to grow in popularity because manufacturers, such as Valencell, claim that the signal from the ear is much more clear than from the wrist.  Additionally, the smart clothing market is projected to more than triple by 2022.

In addition to providing valuable insights into the health of an individual to guide healthcare decisions, Internet-connected wearable devices provide a revolutionizing new data-feed to the insurance industry that can inform the pricing of premiums as well as coverage limits.  Some insurance providers are beginning to require a data feed from the policyholder’s device in order to provide coverage. Of note, security should be a top concern for both users and manufacturers as increasingly personalized data is collected by these devices and attached to real, economic value.  While debates continue on the correct methodology to secure the sensitive data thrown off by wearable devices, most security efforts are focused on utilizing the unique, personalized data from the devices themselves to establish privacy.

While there are many potential uses for wearables, we at Healthcare Growth Partners (HGP) believe the greatest value of wearables is in the field of Remote Patient Monitoring, whereby Internet-connected devices can, in real-time, inform care decisions.  Studies have shown significant benefits from the use of remote patient monitoring systems – one example of which found an approximately 50% reduction in hospital readmissions among a population of 1,000 patients with chronic conditions.  Currently, the conditions most commonly addressed using remote monitoring include sleep apnea, cardiovascular disease, diabetes, and cancer.  Due to increasing incidence of cardiovascular disease, rising geriatric population, and demand for independent and healthy living, Grand View Research projects the remote patient monitoring device market to increase to $1.8 billion by 2026 (excluding the accompanying telehealth services which will have an estimated market size of $31.3 billion by 2023).  In addition, a key barrier to adoption has been overcome now that Medicare has adopted a policy of reimbursing RPM services “just like in-person clinical services with no additional requirements regarding use or originating site of care.”

With all of these favorable market dynamics converging on the wearables industry, we have seen significant investment and M&A activity around companies developing wearable technologies.  The following market landscape displays the companies for which we have seen investment in recent years, grouped by their associated categories as we at HGP see them.

A full list of wearable-related transactions we have tracked can be found in tabular form linked here.

Reaching the Healthcare Mainstream: Wearables and Remote Patient Monitoring

Healthcare Growth Partners (HGP) is a Houston, TX-based Investment Banking & Strategic Advisory firm exclusively focused on the transformational Health IT market. The firm provides  Sell-Side Advisory, Buy-Side Advisory, Capital Advisory, and Pre-Transaction Growth Strategy services, functioning as the exclusive investment banking advisor to over 100 health IT transactions representing over $2 billion in value since 2007.

Tagged With: Accenture, apple, Apple Watch, cancer, diabetes, Health IT, healthcare growth, Hospital Readmissions, M&A, medicare, Partners, Patient Monitoring, remote patient monitoring, sleep apnea, telehealth, Telehealth Services, Valencell, Wearables

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

GE HealthCare to Acquire Caption Health

GE HealthCare to Acquire Caption Health to Expand AI-Guided Ultrasounds

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |